Author
@IPODave IPODave
grade Bx.com/IPODave ↗
IPO/SPAC lifecycle trader posting live tickered add levels with valuation and catalyst reasoning
Trades and tracks recent IPOs, SPACs and new issues, posting
trader score
-0.45
hit rate
45%
mean α
-0.27%
signals 14d
47
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 45% hit rate, -0.27% mean alpha, trader score -0.45. Their last-14d mentions, direction-adjusted, have moved +3.1% since posting (mean over 19 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-10-16 | QQQ | @IPODave | -0.40 | Watches QQQ's July lows amid geopolitical concern. | -0.8% | tweet ↗ |
| 2026-10-16 | SPX | @IPODave | -0.65 | Forecasts a possible final SPX push to 8,000 followed by lower lows in 2027. | · | tweet ↗ |
| 2026-10-15 | TLT | @IPODave | +0.25 | Speculates that large bond buys may anticipate a government backstop for AI debt. | +1.7% | tweet ↗ |
| 2026-10-15 | GME | @IPODave | +0.30 | Interprets unusual action as evidence Cohen may still be pursuing something involving both names. | -11.4% | tweet ↗ |
| 2026-10-15 | EBAY | @IPODave | +0.30 | Interprets unusual action as evidence Cohen may still be pursuing something involving both names. | -1.2% | tweet ↗ |
| 2026-10-15 | · | @IPODave | · | Questions whether the market can stabilize through the end of the week. | · | tweet ↗ |
| 2026-10-13 | LQDA | @IPODave | +0.35 | Credits another source for correctly calling an LQDA bounce | +59.1% | tweet ↗ |
| 2026-10-13 | SPY | @IPODave | +0.15 | Identifies 8,000 as an approaching SPY level | -2.3% | tweet ↗ |
| 2026-10-13 | HTFL | @IPODave | +0.30 | Calls HNGE a strong recent IPO and AI-medical winner | · | tweet ↗ |
| 2026-10-13 | HNGE | @IPODave | +0.65 | Calls HNGE a strong recent IPO and AI-medical winner | +6.1% | tweet ↗ |
| 2026-10-13 | · | @IPODave | · | Expects a near-term push but warns 2027 may become difficult | · | tweet ↗ |
| 2026-10-09 | AAPL | @IPODave | -0.40 | The author expects iPhone and Siri frustration to cost Apple customers. | +3.3% | tweet ↗ |
| 2026-10-09 | MRNA | @IPODave | +0.35 | Warns against shorting MRNA because its chart and prior highs could fuel an upside squeeze. | -11.1% | tweet ↗ |
| 2026-10-09 | CTY | @IPODave | +0.15 | Says biotech dominates current IPO activity despite a sector bear market and may rebound. | · | tweet ↗ |
| 2026-10-09 | TRXB | @IPODave | +0.15 | Says biotech dominates current IPO activity despite a sector bear market and may rebound. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.